Sobre la empresa

Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Our passion and pursuit of potentially life-changing treatments for patients are deeply rooted in over 230 years of distinguished history in Japan.

Dirección

Takeda UK Limited
1 Kingdom Street
London
W2 6BD
United Kingdom

Datos de contacto

Teléfono de información médica
+44 (0)3333 000181

Sitio web de información médica
https://www.globalmedical.takeda.com/

Correo electrónico de Información Médica
MedinfoEMEA@takeda.com

Efectos secundarios y reclamaciones de producto

Adverse Events in the UK should be reported through the Yellow Card Scheme. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Patients can report through the Yellow Card Scheme as well so don't need to consult a doctor first if reporting an Adverse Event.
To report an adverse event for a Takeda product, please contact: AE.GBR-IRL@takeda.com

If your query is regarding a product quality complaint for a Takeda product, please contact: Complaints.UK.Ireland@takeda.com

Please read our Website Privacy Policy before sending us any personal data via email.

Comunicar un efecto adverso por correo electrónico
AE.GBR-IRL@takeda.com

Company Website
https://www.takeda.com/en-gb/

Takeda productos

Los medicamentos marcados con unestán sujetos a un seguimiento adicional que permite la rápida identificación de nueva información de seguridad. Usted puede contribuir comunicando cualquier efecto secundario que conozca.

0-9 a b c d e f g h i j k l m n o p q r s t u v w x y z

Adcetris
(brentuximab vedotin)

ADVATE
(octocog alfa)

ADYNOVI
(rurioctocog alfa pegol)

Alofisel
(darvadstrocel)

Alunbrig
(brigatinib)

CEPROTIN
(protein C)

Cinryze
(C1-esterase inhibitor, human)

Cuvitru
(human normal immunoglobulin)

Edarbi
(azilsartan medoxomil potassium)

Elaprase
(idursulfase)

Elvanse /-Adult
(lisdexamfetamine dimesylate)

Entyvio
(vedolizumab)

Equasym XL
(methylphenidate hydrochloride)

EXKIVITY
(mobocertinib succinate)

FEIBA
(factor VIII inhibitor bypassing activity)

Firazyr
(icatibant acetate)

Fosrenol
(lanthanum carbonate hydrate)

GAMMAGARD S/D
(human normal immunoglobulin)

HyQvia
(human normal immunoglobulin)

Intuniv
(guanfacine hydrochloride)

KIOVIG
(human immunoglobulin)

LIVTENCITY
(maribavir)

Matrifen
(fentanyl)

Mepact
(mifamurtide)

Mezavant XL
(mesalazine)

Natpar
(parathyroid hormone)

NINLARO
(ixazomib citrate)

OBIZUR
(antihaemophilic factor, porcine factor viii:c, susoctocog alfa)

Plenadren
(hydrocortisone)

Prostap DCS
(leuprorelin acetate)

Prothromplex TOTAL
(human prothrombin complex)

Protium
(pantoprazole sodium)

Qdenga
(dengue tetravalent vaccine (live, attenuated))

Reminyl
(galantamine hydrobromide)

Replagal
(agalsidase alfa)

Resolor
(prucalopride succinate)

Revestive
(teduglutide)

RIXUBIS
(nonacog gamma)

TAKHZYRO
(lanadelumab)

VEYVONDI
(vonicog alfa)

Vipdomet
(metformin hydrochloride, alogliptin benzoate)

Vipidia
(alogliptin benzoate)

VPRIV
(velaglucerase alfa)

Xagrid
(anagrelide hydrochloride)

0-9 a b c d e f g h i j k l m n o p q r s t u v w x y z
Ultima actualización: 01/02/2024